SCHEMBL30777150

SCHEMBL30777150

C#Cc1cccc(Nc2nc(OC3CCN(C)CC3(F)F)nc3cc(OC)ccc23)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 10/20 0.38
▸ ERBB2 P04626 8/20 0.38
▸ POLB P06746 3/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ EZH2 Q15910 1/20 0.35
▸ LMNA P02545 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ TSHR P16473 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ HTR2A P28223 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ SRC P12931 1/20 0.33
▸ EPHA2 P29317 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21473410 0.80 ERBB2 (0.58) EGFRERBB2SRCKDR
SCHEMBL21462181 0.80 ERBB2 (0.58) EGFRERBB2SRCKDR
SCHEMBL21462165 0.80 ERBB2 (0.58) EGFRERBB2SRCKDR
SCHEMBL30777161 0.78 EGFR (0.63) EGFRERBB2EPHA2KDREPHB4
SCHEMBL29904972 0.78 EGFR (0.63) EGFRERBB2EPHA2KDREPHB4
SCHEMBL20695020 0.78 EGFR (0.63) EGFRERBB2EPHA2KDREPHB4
SCHEMBL20695016 0.78 EGFR (0.63) EGFRERBB2EPHA2KDREPHB4
SCHEMBL20695031 0.78 EGFR (0.63) EGFRERBB2EPHA2KDREPHB4
SCHEMBL29786138 0.78 EGFR (0.63) EGFRERBB2EPHA2KDREPHB4
SCHEMBL29817923 0.76 EZH2 (0.42) EGFRERBB2POLBEZH2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024016783-A1 6-SUBSTITUTED CHIRALLY PURE DIFLUOROPIPERIDINE QUINAZOLINE DERIVATIVE AND PREPARATION METHOD THEREFOR 威尚(上海)生物医药有限公司 2024-01-25 — — WO disclosed
Send feedback